KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Evolent Health (EVH) Long-Term Debt Issuances (2019 - 2023)

Evolent Health's quarterly Long-Term Debt Issuances came in at $391.4 million in Q4 2023, up 146703.37% quarter-over-quarter from -$267000.0 in Q2 2023.

Evolent Health has reported Long-Term Debt Issuances for 3 years, with the latest figure at $391.4 million in Q4 2023.

  • For the quarter ending Q4 2023, Long-Term Debt Issuances changed N/A year-over-year to $391.4 million; the trailing twelve-month figure through Dec 2023 stood at $647.5 million (up 194.66% YoY), and the FY2023 full-year result was $647.5 million, up 194.66% from the prior year.
  • Long-Term Debt Issuances for Q4 2023 stood at $391.4 million, up from -$267000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $391.4 million in Q4 2023, with the low at -$267000.0 in Q2 2023.
  • Average Long-Term Debt Issuances over 3 years is $186.0 million, with a median of $219.7 million recorded in 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn -
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 19.80 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Evolent Health 467.76 Mn 301.79 Mn 83.77 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 391.43 Mn
Dec 31, 2023 391.43 Mn
Jun 30, 2023 -267,000.00
Jun 30, 2023 -267,000.00
Mar 31, 2023 256.33 Mn
Mar 31, 2023 256.33 Mn
Sep 30, 2022 219.74 Mn
Sep 30, 2022 219.74 Mn
Dec 31, 2019 62.65 Mn
Dec 31, 2019 62.65 Mn